Key releases are ad hoc announcements pursuant to SIX Swiss Exchange Art. 53 LR
Latest press release
Latest press releases and news stories
Go to news archive
Featured News Article
21/01/2026
Press release
Galderma provides update on arbitration case regarding neuromodulator research and development partnership
21/01/2026
News story
IMCAS 2026: Galderma’s scientific presentations
14/01/2026
Press release
TOXINS 2026: Clinical updates on Galderma’s leading neuromodulator portfolio further reinforce its leadership in Injectable Aesthetics
13/01/2026
News story
TOXINS 2026: Galderma’s scientific presentations
17/12/2025
Press release
New published data confirms Nemluvio® (nemolizumab) can rapidly relieve itch and improve sleep in as early as two days in both atopic dermatitis and prurigo nodularis
15/12/2025
News story
Prurigo nodularis: a long road to diagnosis
GALDERMA'S RESPONSE TO AESTHETIC IMPACT OF MEDICATION-DRIVEN WEIGHT LOSS
Discover key insights from the first international consensus guidelines in the full report.
Galderma Annual Reports
MEDIA TOOLKIT: ATOPIC DERMATITIS
Access materials for additional information about the burden of atopic dermatitis.
MEDIA TOOLKIT: PRURIGO NODULARIS
Access materials for additional information about the burden of prurigo nodularis.
MEDIA TOOLKIT: SENSITIVE SKIN AND MODERN LIFESTYLES
Galderma’s scientific response to a growing dermatological challenge.
MEDIA TOOLKIT: MEDICATION-DRIVEN WEIGHT LOSS
Understanding the aesthetic impacts of significant and rapid weight loss.
GET IN TOUCH WITH
25.08.2025
Press release
17.06.2025
Press release
